XOMA Royalty Corporation (NASDAQ:XOMA) — Market Cap & Net Worth
Market Cap & Net Worth: XOMA Royalty Corporation (XOMA)
XOMA Royalty Corporation (NASDAQ:XOMA) has a market capitalization of $738.97 Million ($738.97 Million) as of July 6, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #10388 globally and #2720 in its home market, demonstrating a 2.02% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying XOMA Royalty Corporation's stock price $43.00 by its total outstanding shares 17678742 (17.68 Million). See XOMA capital expenditure intensity to understand how much of operating cash flow is reinvested back into capital assets.
XOMA Royalty Corporation Market Cap History: 2015 to 2026
XOMA Royalty Corporation's market capitalization history from 2015 to 2026. Data shows growth from $470.25 Million to $760.19 Million (6.92% CAGR).
Index Memberships
XOMA Royalty Corporation is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.48 Trillion | 0.03% | #286 of 976 |
|
NASDAQ Composite
IXIC
|
$40.50 Trillion | 0.00% | #1064 of 3165 |
Weight: XOMA Royalty Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
XOMA Royalty Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how XOMA Royalty Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
9.01x
XOMA Royalty Corporation's market cap is 9.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
14.82x
XOMA Royalty Corporation's market cap is 14.82 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $74.60 Million | $5.56 Million | -$53.53 Million | 13.41x | N/A |
| 2017 | $629.36 Million | $52.69 Million | $14.60 Million | 11.94x | 43.12x |
| 2018 | $223.64 Million | $5.30 Million | -$13.34 Million | 42.20x | N/A |
| 2019 | $482.63 Million | $18.37 Million | -$1.98 Million | 26.27x | N/A |
| 2020 | $780.16 Million | $29.39 Million | $13.30 Million | 26.55x | 58.67x |
| 2021 | $368.60 Million | $38.16 Million | $15.80 Million | 9.66x | 23.33x |
| 2022 | $325.29 Million | $6.03 Million | -$17.10 Million | 53.97x | N/A |
| 2023 | $327.06 Million | $4.76 Million | -$40.83 Million | 68.74x | N/A |
| 2024 | $464.60 Million | $28.49 Million | -$13.82 Million | 16.31x | N/A |
| 2025 | $470.08 Million | $52.15 Million | $31.71 Million | 9.01x | 14.82x |
Competitor Companies of XOMA by Market Capitalization
Companies near XOMA Royalty Corporation in the global market cap rankings as of July 6, 2026.
Key companies related to XOMA Royalty Corporation by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #221 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #431 globally with a market cap of $64.60 Billion USD.
- UCB SA (BR:UCB): Ranked #544 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #570 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #221 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $528.04 |
| #431 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $654.27 |
| #544 | UCB SA | BR:UCB | $49.68 Billion | €259.50 |
| #570 | Argen-X | BR:ARGX | $47.14 Billion | €830.80 |
XOMA Royalty Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, XOMA Royalty Corporation's market cap moved from $470.25 Million to $ 760.19 Million, with a yearly change of 6.92%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $760.19 Million | +61.71% |
| 2025 | $470.08 Million | +1.18% |
| 2024 | $464.60 Million | +42.05% |
| 2023 | $327.06 Million | +0.54% |
| 2022 | $325.29 Million | -11.75% |
| 2021 | $368.60 Million | -52.75% |
| 2020 | $780.16 Million | +61.65% |
| 2019 | $482.63 Million | +115.81% |
| 2018 | $223.64 Million | -64.47% |
| 2017 | $629.36 Million | +743.60% |
| 2016 | $74.60 Million | -84.14% |
| 2015 | $470.25 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 6th, 2026 the market cap of XOMA Royalty Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $738.97 Million USD |
| MoneyControl | $738.97 Million USD |
| MarketWatch | $738.97 Million USD |
| marketcap.company | $738.97 Million USD |
| Reuters | $738.97 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About XOMA Royalty Corporation
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with co… Read more